Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

L.A. McKeown

August 05, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia

L.A. McKeown

November 24, 2020

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

Advertisement

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

Scientific Statement Reviews Current Antithrombotic Options in PAD

Platelet Hyperreactivity Score May Improve CVD Risk Detection

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

October 2023 News Roundup

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

AHA Scientific Statement Addresses Health Disparities in PAD

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Worse Complications After PVI in Women Highlight Research Gaps

August 2022 News Roundup

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

February 2022 News Roundup

December 2021 News Roundup

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

PAD Continues to Elude Clinicians, Despite Gains: AHA

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content